Búsqueda | Biblioteca Virtual en Salud

RSS XML

Resultados 1 - 4 de 4

1 Próxima > >>

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults.

Costa Clemens, Sue Ann; Marchevsky, Natalie; Kelly, Sarah; Felle, Sally; Eldawi, Ahmed; Rajasingam, Rupetha; Mahmud, Rawan; Lambe, Teresa; Voysey, Merryn; Gonzalez, Isabela; Milan, Eveline Pipolo; Justino, Maria Cleonice; Bibi, Sagida; Aley, Parvinder; Clemens, Ralf; Pollard, Andrew J.

Hum Vaccin Immunother ; 19(2): 2233400, 2023 08 01.

Artículo en Inglés | MEDLINE | ID: mdl-37438960

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.

Mentzer, Alexander J; O'Connor, Daniel; Bibi, Sagida; Chelysheva, Irina; Clutterbuck, Elizabeth A; Demissie, Tesfaye; Dinesh, Tanya; Edwards, Nick J; Felle, Sally; Feng, Shuo; Flaxman, Amy L; Karp-Tatham, Eleanor; Li, Grace; Liu, Xinxue; Marchevsky, Natalie; Godfrey, Leila; Makinson, Rebecca; Bull, Maireid B; Fowler, Jamie; Alamad, Bana; Malinauskas, Tomas; Chong, Amanda Y; Sanders, Katherine; Shaw, Robert H; Voysey, Merryn; Snape, Matthew D; Pollard, Andrew J; Lambe, Teresa; Knight, Julian C.

Nat Med ; 29(1): 147-157, 2023 01.

Artículo en Inglés | MEDLINE | ID: mdl-36228659

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.

Marchevsky, Natalie Gabrielle; Li, Grace; Aley, Parvinder; Costa Clemens, Sue Ann; Barrett, Jordan Richard; Belij-Rammerstorfer, Sandra; Bibi, Sagida; Clutterbuck, Elizabeth; Dold, Christina; Felle, Sally; Flaxman, Amy; Folegatti, Pedro; Jenkin, Daniel; Gilbert, Sarah; Kelly, Sarah; Lambe, Teresa; Plested, Emma; Ramasamy, Maheshi; Singh, Nisha; Smith, Holly; Taylor, Stephen; Weckx, Lily; Pollard, Andrew John; Voysey, Merryn.

EBioMedicine ; 81: 104128, 2022 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-35779491

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults

Clemens, Sue Ann Costa; Marchevsky, Natalie; Kelly, Sarah; Felle, Sally; Eldawi, Ahmed; Rajasingam, Rupetha; Mahmud, Rawan; Lambe, Teresa; Voysey, Merryn; Gonzalez, Isabela; Milan, Eveline Pipolo; Justino, Maria Cleonice Aguiar; Bibi, Sagida; Aley, Parvinder; Clemens, Ralf; Pollard, Andrew J.

Clemens, Sue Ann Costa et al. Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults. Human Vaccines and Immunotherapeutics, v. 19, n. 2, 2023. DOI: https://doi.org/10.1080/21645515.2023.2233400. Disponível em: https://www.tandfonline.com/doi/epdf/10.1080/21645515.2023.2233400?needAccess=true&role=button.

Artículo en Inglés | IED | ID: ied-6852

Resultados 1 - 4 de 4

1 Próxima > >>

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults.

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults